Contact us
Let’s discover the source of new possibilities
An Essential Substance for the Human Body
Polyunsaturated fatty acids are essential, health-promoting nutrients that are widely used in medicine, pharmaceutics, cosmetics, nutrition, and other fields. Suitable plant and animal sources for these lipids are limited, but alternatives have been actively researched and developed in the last three decades, especially those produced microbiologically. The omega-6 fatty acid segment is mainly segmented into Linolenic Acid and Arachidonic Acid. Another omega-6 fatty acid whose interest in the nutraceutical industry is rising is Dihomo-Gama Linoleic Acid. In contrast to Arachidonic Acid, Dihomo-Gama Linoleic Acid normally occurs only as an intermediate in the biosynthesis of Arachidonic Acid in fungi and algae. Arachidonic acid and Dihomo-Gama Linoleic Acid are both an essential substance for the human body.
Sustainable
Natural
Clean
Safe
Efficient
Stable
Standardized
An esssential substance
for the human body:
- Anti-acne, atopic dermatitis and other skin conditions
- Anti-inflammatory (oral intake and atopic administration)
- Anti-sclerotic activities
- Reduces symptoms of premenstrual syndrome
- Assists with allergic asthma
- Can prevent hair loss and baldness.
An omega-6 LC-PUFA with many health-beneficial and therapeutic applications
Long-chain polyunsaturated fatty acids (LC-PUFA) are essential, health-promoting nutrients widely used in medicine, pharmaceutics, cosmetics, nutrition, and other fields. Plants do not produce LC-PUFA, and animal (mainly fish) sources for these lipids are limited and unsustainable. Natural and renewable alternatives for LC-PUFA have been actively researched and developed in the last three decades, especially those produced microbiologically. The omega-6 fatty acid segment on the market is mainly presented by Linolenic acid and Arachidonic acid. A rare omega-6 fatty acid that is gaining an increasing interest in the nutraceutical industry is Dihomo-Gamma Linolenic Acid (DGLA). DGLA occurs typically only as an intermediate in Arachidonic acid’s biosynthesis in animals and in LC-PUFA-synthetizing fungi and algae. Arachidonic acid and DGLA are both essential substances for the human body but exhibit a different range of activities. DGLA is recognized as an anti-inflammatory, anti-proliferative, and anti-atherogenic fatty acid; it holds promise to treat various inflammatory conditions, such as skin inflammatory diseases and asthma.
APPLICATIONS
Dihomo-Gama Linoleic Acid and Arachidonic Acid will be commercially produced on the third quarter of 2021, with commercial production rights through Ben Gurion University.
To learn more about dihomo-gama linoleic acid and arachidonic acid,
download our brochure
